FLIP regulation of HO-1 and TNF signalling in human acute myeloid leukemia provides a unique secondary anti-apoptotic mechanism
about
Aberrant nuclear factor-kappa B activity in acute myeloid leukemia: from molecular pathogenesis to therapeutic targetRetinoic acid synergizes ATO-mediated cytotoxicity by precluding Nrf2 activity in AML cellsIbrutinib inhibits SDF1/CXCR4 mediated migration in AMLPleiotropic functions of EAPII/TTRAP/TDP2: cancer development, chemoresistance and beyondSystemic use of tumor necrosis factor alpha as an anticancer agentProtection of acute myeloid leukaemia cells from apoptosis induced by front-line chemotherapeutics is mediated by haem oxygenase-1Bortezomib induces heme oxygenase-1 expression in multiple myelomaPurification and identification of a polysaccharide from medicinal mushroom Amauroderma rude with immunomodulatory activity and inhibitory effect on tumor growthThe role of TRADD in death receptor signalingA combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemiaAttenuation of dexamethasone-induced cell death in multiple myeloma is mediated by miR-125b expressionCXXC5 (retinoid-inducible nuclear factor, RINF) is a potential therapeutic target in high-risk human acute myeloid leukemiaLinear polyubiquitin chains: a new modifier involved in NFκB activation and chronic inflammation, including dermatitis.Anti-leukemia activity of NSC-743380 in SULT1A1-expressing acute myeloid leukemia cells is associated with inhibitions of cFLIP expression and PI3K/AKT/mTOR activities.
P2860
Q26995561-D174F065-DA8F-435A-BCE4-A9234FB0AEA1Q28393380-487B7868-1B6B-4E12-8841-5DDE2D35BE91Q34042250-20B4206E-2CAA-45DF-9B8D-71C2F5423F5BQ35600743-3546F7F2-34B5-4C5E-84B8-E651A83FE294Q35640180-6395F89F-CFB2-4CFB-9899-B7EA1664EFBDQ35640339-340FDA3E-FA18-4861-B95F-79C8E36F025EQ36059668-7A0671B0-0191-46A1-834A-FB9555C5CF6FQ36232168-56A0DAE5-9CC5-43EF-B96A-A1E144C922C5Q36920268-A0FFD548-18C1-4D0D-A132-CE836E23F8F3Q36926129-A7556819-A37A-4B93-BF1D-C21EE3D765F8Q37079785-374E4517-64AF-4737-B398-DF17E4D39790Q37299309-48C5D06E-4B40-482E-A099-E8D374F81102Q39177871-FE95A90E-6E3F-495A-9C57-1AD82A565A6DQ46237281-0358C239-195D-499B-8F9B-208DEDF703B0
P2860
FLIP regulation of HO-1 and TNF signalling in human acute myeloid leukemia provides a unique secondary anti-apoptotic mechanism
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
FLIP regulation of HO-1 and TN ...... ndary anti-apoptotic mechanism
@ast
FLIP regulation of HO-1 and TN ...... ndary anti-apoptotic mechanism
@en
type
label
FLIP regulation of HO-1 and TN ...... ndary anti-apoptotic mechanism
@ast
FLIP regulation of HO-1 and TN ...... ndary anti-apoptotic mechanism
@en
prefLabel
FLIP regulation of HO-1 and TN ...... ndary anti-apoptotic mechanism
@ast
FLIP regulation of HO-1 and TN ...... ndary anti-apoptotic mechanism
@en
P2093
P2860
P1433
P1476
FLIP regulation of HO-1 and TN ...... ndary anti-apoptotic mechanism
@en
P2093
David J MacEwan
Kristian M Bowles
Lyubov Zaitseva
Stuart A Rushworth
Susana Langa
P2860
P304
P356
10.18632/ONCOTARGET.100909
P407
P577
2010-09-01T00:00:00Z